Skip to main content

. 1967 Nov 4;4(5574):264–268. doi: 10.1136/bmj.4.5574.264

Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

P L Boardman, F D Hart

PMCID: PMC1748911 PMID: 4861386

264

Images in this article

Fig. 1
on p.265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

FREMONT-SMITH K., BAYLES T. B. SALICYLATE THERAPY IN RHEUMATOID ARTHRITIS. JAMA. 1965 Jun 28;192:1133–1136. doi: 10.1001/jama.1965.03080260021006. [DOI] [PubMed] [Google Scholar]
HART F. D., BOARDMAN P. L. INDOMETHACIN: A NEW NON-STEROID ANTI-INFLAMMATORY AGENT. Br Med J. 1963 Oct 19;2(5363):965–970. doi: 10.1136/bmj.2.5363.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
Jick H., Pinals R. S., Ullian R., Slone D., Muench H. Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet. 1965 Dec 11;2(7424):1203–1205. doi: 10.1016/s0140-6736(65)90632-x. [DOI] [PubMed] [Google Scholar]
SMYTH C. J., CLARK G. M. Phenylbutazone in rheumatoid arthritis. J Chronic Dis. 1957 Jun;5(6):734–750. doi: 10.1016/0021-9681(57)90081-4. [DOI] [PubMed] [Google Scholar]
VAUGHN P. P., HOWELL D. S., KIEM I. M. The comparative effects of phenylbutazone and G27202 (metabolite I) in patients with rheumatoid arthritis: an assessment of methods for antirheumatic drug evaluation. Arthritis Rheum. 1959 Jun;2(3):212–223. doi: 10.1002/1529-0131(195906)2:3<212::aid-art1780020304>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
WRIGHT V. Some observations on diurnal variation of grip. Clin Sci. 1959 Feb;18(1):17–23. [PubMed] [Google Scholar]

ACTIONS

RESOURCES